Clinical trials recruiting for Breast Lobular Carcinoma In Situ
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Tamoxifen | 3 |
| Acolbifene Hydrochloride | 1 |
| Omega-3-Acid Ethyl Esters | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 4 |
| Kansas | 3 |
| Illinois | 2 |
| Michigan | 2 |
| Arizona | 1 |
| California | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| South Carolina | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Related conditions
Trials recruiting for Breast Lobular Carcinoma In Situ often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Lobular Carcinoma In Situ trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.